Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer.
about
Combining Carcinoembryonic Antigen and Platelet to Lymphocyte Ratio to Predict Brain Metastasis of Resected Lung Adenocarcinoma PatientsPrognostic value of PLR in various cancers: a meta-analysis.Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patientsThe platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation.Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapyClinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer.Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysisA new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancerThe Prognostic Value of PLR in Lung Cancer, a Meta-analysis Based on Results from a Large Consecutive Cohort.Clinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio (PLT-PLR) in patients with surgically resected non-small cell lung cancer.C-reactive protein/albumin ratio as prognostic score in oral squamous cell carcinoma.Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancerOutcomes and prognostic factors of chemotherapy for patients with locally advanced or metastatic pulmonary squamous cell carcinoma.A retrospective evaluation of associations between chronic obstructive pulmonary disease, smoking, and efficacy of chemotherapy and selected laboratory parameters in patients with advanced non-small cell lung cancer.Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysisPrognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients.Prognostic significance of neutrophil-lymphocyteratio/platelet-lymphocyteratioin lung cancers: a meta-analysis.Predictive value of inflammatory indexes on the chemotherapeutic response in patients with unresectable lung cancer: A retrospective study.Prognostic and clinicopathological significance of platelet to lymphocyte ratio in esophageal cancer: a meta-analysis.[Impact of the Pretreatment or Posttreatment NLR and PLR on the Response of First Line Chemotherapy and the Outcomes in Patients with Advanced Non-small Cell Lung Cancer].Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancerThe Position of Neutrophils-To-Lymphocytes and Lymphocytes-To-Platelets Ratio as Predictive Markers of Progression and Prognosis in Patients with Non-Small Cell Lung Cancer
P2860
Q33794912-3D6614FF-9999-4C21-8D17-FBFD2884CB7CQ33812584-DBB723EB-D8F7-407A-8240-79C9C6549A8CQ35663441-2602F45B-48BE-4972-AE6F-70F2803B2A24Q35783836-EACB93FD-1A83-4DAD-8D36-3A720F351A63Q35797850-F9C9B1F6-C888-41C5-9814-1B28C8406B8CQ36028749-3BF1AF59-03CA-43E4-8C8C-2DFB564055FAQ36640764-529AF399-2469-46E9-BA1E-E45746164433Q36650991-B8DC4FF4-7391-44A5-A691-27006FA7882FQ37170527-0717E9F8-E893-485C-8723-7335E3BE4C10Q37310842-C3F88086-C717-49F9-803F-7730D6938F6DQ37392676-5D8BDFC7-D579-4E80-9AE4-4A86B13E2BE5Q37408199-3E4F0DB2-30E1-42B0-B148-AEE3CC1ACF16Q37580326-BCC087D3-4C8A-4938-924F-F24C8DE14E80Q37643560-237C05DD-C16B-4B74-AE2C-8801AFF29925Q37727663-C22422AB-941E-4230-9666-00C113454C4BQ38650153-E799A4D5-8D79-438C-B7C0-E639E0F599FBQ39647693-84E01C38-C059-4471-B666-5CB7E0E38ADDQ42314596-8D9DBA63-7B29-4EA3-A70A-F6953CF714EBQ50190172-027D5E08-6019-4A02-B47D-058F5DA3774CQ54939284-AA09E5FC-5989-4510-8D35-94254B2248AAQ55447528-7BACF1CE-B345-484B-8A05-513B00518451Q57072196-807169DA-A3DA-44E2-9D45-31D34766A475Q58800512-5A7B1F89-72DD-4804-991C-AFDA424727EB
P2860
Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pretreatment platelet-to-lymph ...... th non-small cell lung cancer.
@en
Pretreatment platelet-to-lymphocyte ratio
@nl
type
label
Pretreatment platelet-to-lymph ...... th non-small cell lung cancer.
@en
Pretreatment platelet-to-lymphocyte ratio
@nl
prefLabel
Pretreatment platelet-to-lymph ...... th non-small cell lung cancer.
@en
Pretreatment platelet-to-lymphocyte ratio
@nl
P2093
P2860
P1476
Pretreatment platelet-to-lymph ...... th non-small cell lung cancer.
@en
P2093
Fangfang Chen
Hongbing Liu
Yanwen Yao
Yunfen Wang
Zhaofeng Wang
P2860
P304
P356
10.3978/J.ISSN.2072-1439.2013.12.34
P577
2013-12-01T00:00:00Z